Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI0382 on Hepatic Glycogen Metabolism in T2DM
NCT03555994Phase 2Completed
- Sponsor
- MedImmune
- Start
- May 2018
- Primary completion
- Apr 2021
- Modality
- Peptides
- Countries
- 3
01
Overview
A Phase 2 trial of cotadutide in type 2 diabetes mellitus (T2DM), obesity, sponsored by MedImmune. Started May 2018; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT03555994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03555994.